삼성바이오로직스: directors' dealings · South Korea · DART (FSS)

Explore the full insider trade history of 삼성바이오로직스, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 삼성바이오로직스 has recorded 1 public disclosures. Market capitalisation: €64,159.3bn. The latest transaction was reported on 5 March 2026 — Other. Among the most active insiders: 삼성바이오로직스. All data is openly available.